Brian J. Kieser
Interim CEO & DirectorMr. Brian J. Kieser, CPA, is Director of NEXGEL, Inc. from May 6, 2026 and serves as its Interim Chief Executive Officer from August 21, 2026. Mr. Kieser serves as Founding Partner, President, Managing Partner and Director of Fountainhead Investment Partners, LLC. Mr. Kieser also serves as Chief Executive Officer of Nvision Biomedical Technologies, LLC. He is also the Founder of Nvision Biomedical Technologies. Mr. Kieser is the Founder and Chief Executive Officer of Fountainhead Biomedical Holdings, a San Antonio–based venture platform designed to create, scale and commercialize next-generation medical technologies. Through Fountainhead Biomedical Holdings, Mr. Kieser has assembled a vertically integrated ecosystem of companies focused on orthopedic medical devices, regenerative biologics and advanced biomedical manufacturing. The platform includes Lockhill Advanced Manufacturing Technologies—each purpose-built to solve critical challenges in surgery, tissue healing and medical device production. Mr. Kieser holds many issued patents covering structural encoding technologies and methods used to uniquely identify implanted medical devices, advancing traceability, device intelligence and safety within the medical device industry. Mr. Kieser earned his BBA in Accounting from the University of Texas at El Paso and is a CPA licensed to practice in Texas.
Positions
- Company NameNEXGEL, Inc.Stock CodeNXGLPositionInterim CEO & DirectorRelated SecuritiesColleagues
- SMSteven Mark GlassmanIndependent Chairman
- IBIan BlackmanChief Financial Officer
- GJGregory J. RobbVice President of Operations
- VPValter PintoManaging Director of KCSA Strategic Communications
- JBJerome Bernard ZeldisIndependent Director & Chairman of Scientific Advisory Board
- SAStephen A. BrigidoMember of Scientific Advisory Board
- SPStephen P. BancoMember of Scientific Advisory Board
